2008-06-27 00:01:31 - www.companiesandmarkets.com adds new report - Premium Company Profile - Johnson and Johnson

www.companiesandmarkets.com/Summary-Company-Profile/Premium-Comp ..
Introduction

Johnson & Johnson (J&J) has outlined its future growth strategy through a strong portfolio of products for its pharmaceutical and consumer business. The company´s growth plan is based on three strategic measures: expansion in developing markets, new technologies, and selected acquisitions.



Scope

Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial

trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies


Highlights

The company manufactures healthcare products, as well as provides health care related services to the consumer, pharmaceutical, and medical devices and diagnostics markets. J&J has more than 250 operating companies conducting business across the globe.



The revenues of J&J have consistently grown during 2002-2006. The company´s revenues grew at a CAGR of 10%, from $36,298 million in 2002 to $53,324 million in 2006. The five-year compound annual growth rates for the geographic markets worldwide, the US, and international sales were 10.5%, 8.5%, and 13.5%, respectively.



In November 2007, DePuy Spine, a J&J subsidiary company, signed a definitive agreement to acquire certain assets (including intellectual property rights related to the treatment of vertebral compression fractures) from an Israel-based company Disc-O-Tech Medical Technologies.



Reasons to Purchase

Access all the important information and analysis on the company in a single report
Understand company´s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company´s adjusted five year financial data along with key ratios and market capitalization